newsfilter
← Latest News
PR Newswire·

Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring

PLSM
  • Pulsenmore Ltd. completed CE European registration for Pulsenmore FC, its home ultrasound system for monitoring follicular development & endometrial thickness during IVF & fertility preservation.
  • This marks the company's second product authorized in Europe & its first expansion beyond prenatal care into the broader women's health market.
  • The system enables patients to self-perform scans at home with remote guidance from physicians to reduce frequent clinic visits & support treatment continuity.
  • Data from ESHRE indicates over 1.15 million assisted reproduction cycles occurred in Europe in 2023, with many requiring repeated scans that the home system aims to mitigate.
  • A clinical study at Rabin Medical Center showed high agreement between home scans & in-clinic examinations, along with high satisfaction from patients & staff.
  • Pulsenmore FC previously received Israeli Ministry of Health approval & has a commercial agreement with Clalit Health Services established in January 2026.
  • CEO Dr. Elazar Sonnenschein stated this registration signals the company's evolution from a single-product focus to a broader home ultrasound platform for women's health.
  • The registration allows Pulsenmore to market & sell the system across European markets, expanding its portfolio to address multiple stages of the women's health journey.